Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Mirati Therapeutics Inc.

Start price
Target price
Perf. (%)
€95.50
26.11.22
-
26.11.23
-45.74%
27.11.23

Bluebird Bio Inc.

Start price
Target price
Perf. (%)
€2.59
28.10.23
€1.00
28.10.24
8.65%
11.11.23

PTC Therapeutics Inc.

Start price
Target price
Perf. (%)
€17.20
28.10.23
€8.00
28.10.24
-4.07%
11.11.23

Probably not worthwhile Investment
Revenue decline/stagnation expected
Lower EBIT Margin than peer group
negative Cash Flow expected
buy
Integra LifeSciences Holdings Corp

Start price
Target price
Perf. (%)
€44.40
26.10.22
€48.00
26.10.23
-24.77%
26.10.23

buy
Syneos Health, Inc.

Start price
Target price
Perf. (%)
€49.56
25.10.22
€50.00
25.10.23
-17.27%
26.10.23

Medpace Holdings Inc

Start price
Target price
Perf. (%)
€218.90
25.10.22
€190.00
25.10.23
11.47%
26.10.23

Could be worthwhile Investment >10% per year
buy
Teladoc Health Inc

Start price
Target price
Perf. (%)
€20.12
16.09.23
-
16.10.23
-10.64%
17.10.23

buy
Mirati Therapeutics Inc.

Start price
Target price
Perf. (%)
€59.10
05.10.23
-
05.10.24
-8.93%
15.10.23

Could be worthwhile Investment >10% per year
buy
Davita Inc.

Start price
Target price
Perf. (%)
€72.54
11.10.23
-
11.10.24
-3.61%
14.10.23

Acadia Pharmaceuticals

Start price
Target price
Perf. (%)
€19.60
30.09.23
€9.00
30.09.24
11.22%
14.10.23

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
Bruker Corp.

Start price
Target price
Perf. (%)
€58.50
06.10.22
€70.00
06.10.23
1.71%
07.10.23

buy
Teladoc Health Inc

Start price
Target price
Perf. (%)
€22.88
14.07.23
€26.00
14.07.24
-22.31%
01.10.23

Significant cyclical dependencies
ROE lower than 10% per year
high free float
Little known brand
PTC Therapeutics Inc.

Start price
Target price
Perf. (%)
€24.00
16.09.23
€12.00
16.09.24
-13.33%
30.09.23

Probably not worthwhile Investment
Revenue decline/stagnation expected
Lower EBIT Margin than peer group
negative Cash Flow expected
Iovance Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€5.32
16.09.23
€2.00
16.09.24
-18.14%
30.09.23

buy
Iovance Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€4.35
14.09.23
-
14.09.24
22.42%
16.09.23

Could be very worthwhile Investment >20% year
buy
PTC Therapeutics Inc.

Start price
Target price
Perf. (%)
€25.20
15.09.23
-
15.09.24
-4.76%
16.09.23

Could be very worthwhile Investment >20% year
buy
Healthequity Inc.

Start price
Target price
Perf. (%)
€63.50
26.08.22
€66.00
26.08.23
-0.79%
27.08.23

buy
Amicus Therapeutics Inc.

Start price
Target price
Perf. (%)
€12.50
23.08.22
-
23.08.23
-7.20%
24.08.23

buy
Sage Therapeutics Inc.

Start price
Target price
Perf. (%)
€16.70
07.08.23
-
07.08.24
8.38%
19.08.23

buy
Fibrogen Inc.

Start price
Target price
Perf. (%)
€1.23
09.08.23
-
09.08.24
-5.69%
19.08.23

buy
Global Blood Therapeutics Inc

Start price
Target price
Perf. (%)
€66.40
18.08.22
-
18.08.23
3.22%
19.08.23

Sage Therapeutics Inc.

Start price
Target price
Perf. (%)
€19.90
11.08.23
-
11.08.24
-9.05%
19.08.23

buy
Nektar Therapeutics

Start price
Target price
Perf. (%)
€0.95
07.08.23
-
07.08.24
-29.26%
19.08.23

Could be worthwhile Investment >10% per year
Good culture
Capable Management
Few uniques
Sage Therapeutics Inc.

Start price
Target price
Perf. (%)
€15.10
07.08.23
-
07.08.24
21.19%
18.08.23

Capable Management
Risky Investment
No uniques
buy
PTC Therapeutics Inc.

Start price
Target price
Perf. (%)
€51.50
16.08.22
-
16.08.23
-27.77%
16.08.23